Sensitivity and mediation analyses for the change in left ventricular diastolic function
In a next step, sensitivity analysis in clinically relevant subgroups has been carried out (Fig. Effect of empagliflozin 10 mg/day vs. placebo on the primary study endpoint after 12 weeks of intervention in clinically-relevant subgroups. Beta-estimates for the effect of empagliflozin 10 mg/day compared to placebo on To decipher the contribution of the systemic effects of empagliflozin on the change in left ventricular diastolic function, a mediation analysis for the effect of 12-week empagliflozin on 